264 related articles for article (PubMed ID: 16823874)
21. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment swallowing exercises improve swallow function after chemoradiation.
Carroll WR; Locher JL; Canon CL; Bohannon IA; McColloch NL; Magnuson JS
Laryngoscope; 2008 Jan; 118(1):39-43. PubMed ID: 17989581
[TBL] [Abstract][Full Text] [Related]
23. Swallowing outcomes after radiotherapy for laryngeal carcinoma.
Hutcheson KA; Barringer DA; Rosenthal DI; May AH; Roberts DB; Lewin JS
Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):178-83. PubMed ID: 18283161
[TBL] [Abstract][Full Text] [Related]
24. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
[TBL] [Abstract][Full Text] [Related]
25. Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature.
Rieger JM; Zalmanowitz JG; Wolfaardt JF
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):581-7. PubMed ID: 16697144
[TBL] [Abstract][Full Text] [Related]
26. Effects of radiation therapy and voluntary maneuvers on swallow functioning in head and neck cancer patients.
Lazarus CL
Clin Commun Disord; 1993; 3(4):11-20. PubMed ID: 8111360
[No Abstract] [Full Text] [Related]
27. Analysis of factors influencing Dysphagia severity following treatment of head and neck cancer.
Nguyen NP; Frank C; Moltz CC; Karlsson U; Nguyen PD; Ward HW; Vos P; Smith HJ; Huang S; Nguyen LM; Lemanski C; Ludin A; Sallah S
Anticancer Res; 2009 Aug; 29(8):3299-304. PubMed ID: 19661348
[TBL] [Abstract][Full Text] [Related]
28. Role of videofluorography swallow study in management of dysphagia in neurologically compromised patients.
Barbiera F; Condello S; De Palo A; Todaro D; Mandracchia C; De Cicco D
Radiol Med; 2006 Sep; 111(6):818-27. PubMed ID: 16896559
[TBL] [Abstract][Full Text] [Related]
29. Pharyngoesophageal stricture after treatment for head and neck cancer.
Wang JJ; Goldsmith TA; Holman AS; Cianchetti M; Chan AW
Head Neck; 2012 Jul; 34(7):967-73. PubMed ID: 21953721
[TBL] [Abstract][Full Text] [Related]
30. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
31. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
[No Abstract] [Full Text] [Related]
32. Aspiration in chemoradiated patients with head and neck cancer.
Langerman A; Maccracken E; Kasza K; Haraf DJ; Vokes EE; Stenson KM
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1289-95. PubMed ID: 18086974
[TBL] [Abstract][Full Text] [Related]
33. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ
J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465
[TBL] [Abstract][Full Text] [Related]
34. Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer.
Pauloski BR; Rademaker AW; Logemann JA; Discekici-Harris M; Mittal BB
Head Neck; 2015 Nov; 37(11):1575-82. PubMed ID: 24909649
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
Epstein JB; Beaumont JL; Gwede CK; Murphy B; Garden AS; Meredith R; Le QT; Brizel D; Isitt J; Cella D
Cancer; 2007 May; 109(9):1914-22. PubMed ID: 17377917
[TBL] [Abstract][Full Text] [Related]
36. Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancers.
Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
Radiother Oncol; 2010 Oct; 97(1):132-5. PubMed ID: 20817288
[TBL] [Abstract][Full Text] [Related]
37. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
[TBL] [Abstract][Full Text] [Related]
38. Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives.
Wilson JA; Carding PN; Patterson JM
Otolaryngol Head Neck Surg; 2011 Nov; 145(5):767-71. PubMed ID: 21746839
[TBL] [Abstract][Full Text] [Related]
39. The dysphagia diagnostic procedure as a treatment efficacy trial.
Logemann JA
Clin Commun Disord; 1993; 3(4):1-10. PubMed ID: 8111359
[TBL] [Abstract][Full Text] [Related]
40. Long-term aspiration following treatment for head and neck cancer.
Nguyen NP; Moltz CC; Frank C; Vos P; Smith HJ; Karlsson U; Nguyen LM; Rose S; Dutta S; Nguyen N; Sallah S
Oncology; 2008; 74(1-2):25-30. PubMed ID: 18544956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
